Focal adhesion |
197 |
<0.001 |
Gap junction |
87 |
<0.001 |
Cytokine -cytokine receptor interaction |
234 |
<0.001 |
Cell adhesion molecules CAMS |
129 |
<0.001 |
Dilated cardiomyopathy |
86 |
<0.001 |
Chemokine signaling pathway |
183 |
<0.001 |
Hypertrophic cardiomyopathy |
79 |
<0.001 |
Leukocyte transendothelial migration |
111 |
<0.001 |
Hedgehog signaling pathway |
54 |
<0.001 |
Regulation of actin cytoskeleton |
207 |
<0.001 |
Melanogenesis |
99 |
<0.001 |
ECM receptor interaction |
83 |
<0.001 |
Axon guidance |
127 |
<0.001 |
Pathways in cancer |
322 |
<0.001 |
Basal cell carcinoma |
54 |
<0.001 |
Arrhythmogenic right ventricular cardiomyopathy |
71 |
0.001 |
Complement and coagulation cascades |
64 |
0.001 |
Neuroactive ligand receptor interaction |
231 |
0.001 |
JAK-STAT signaling pathway |
130 |
0.001 |
Leishmania infection |
70 |
0.005 |
TOLL-like receptor signaling pathway |
87 |
0.006 |
Glycosaminoglycan biosynthesis chondroitin sulfate |
22 |
0.006 |
Vascular smooth muscle contraction |
113 |
0.006 |
Hematopoietic cell lineage |
81 |
0.006 |
Calcium signaling pathway |
169 |
0.007 |
TGF-β signaling pathway |
85 |
0.009 |
MAPK signaling pathway |
257 |
0.015 |
Glycosaminoglycan biosynthesis heparan sulfate |
26 |
0.02 |
Melanoma |
70 |
0.039 |